(CPS) Cooper Stnd - Overview
Sector: Consumer CyclicalIndustry: Auto Parts | Exchange NYSE (USA) | Currency USD | Market Cap: 498m | Total Return 70.2% in 12m
Stock: Sealing Systems, Fluid Handling, Automotive Parts
Total Rating 53
Risk 57
Buy Signal -0.95
| Risk 5d forecast | |
|---|---|
| Volatility | 70.1% |
| Relative Tail Risk | -15.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.97 |
| Alpha | 43.40 |
| Character TTM | |
|---|---|
| Beta | 2.192 |
| Beta Downside | 2.414 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.93% |
| CAGR/Max DD | 0.62 |
EPS (Earnings per Share)
Revenue
Description: CPS Cooper Stnd March 04, 2026
Cooper-Standard Holdings Inc. manufactures sealing and fluid handling systems. These products are primarily supplied to automotive original equipment manufacturers (OEMs) for passenger vehicles and light trucks. The automotive parts sector is cyclical, tied to vehicle production volumes.
The companys sealing systems include dynamic and static seals, encapsulated glass, and specialty sealing products. Their fluid handling systems encompass fuel and brake delivery systems, as well as fluid transfer systems like hoses and quick connects. This business model relies on long-term contracts with major automotive manufacturers.
For more detailed financial and operational data, ValueRay offers in-depth company analyses.
Headlines to watch out for
- Automotive production volumes directly impact sealing and fluid systems demand
- Raw material cost fluctuations affect manufacturing profitability
- OEM new vehicle platforms drive product development and sales
- Global economic conditions influence automotive industry performance
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -4.17m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.53 > 1.0 |
| NWC/Revenue: 7.40% < 20% (prev 8.37%; Δ -0.97% < -1%) |
| CFO/TA 0.04 > 3% & CFO 64.4m > Net Income -4.17m |
| Net Debt (1.06b) to EBITDA (172.9m): 6.16 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.7m) vs 12m ago 4.13% < -2% |
| Gross Margin: 11.72% > 18% (prev 0.11%; Δ 1.16k% > 0.5%) |
| Asset Turnover: 153.7% > 50% (prev 157.6%; Δ -3.86% > 0%) |
| Interest Coverage Ratio: 0.45 > 6 (EBITDA TTM 172.9m / Interest Expense TTM 115.9m) |
Altman Z'' -0.25
| A: 0.11 (Total Current Assets 881.1m - Total Current Liabilities 678.4m) / Total Assets 1.83b |
| B: -0.26 (Retained Earnings -474.7m / Total Assets 1.83b) |
| C: 0.03 (EBIT TTM 52.2m / Avg Total Assets 1.78b) |
| D: -0.32 (Book Value of Equity -607.8m / Total Liabilities 1.92b) |
| Altman-Z'' Score: -0.25 = B |
Beneish M -4.00
| DSRI: 1.06 (Receivables 465.4m/436.6m, Revenue 2.74b/2.73b) |
| GMI: 0.95 (GM 11.72% / 11.09%) |
| AQI: -1.90k (AQ_t -330.6 / AQ_t-1 0.17) |
| SGI: 1.00 (Revenue 2.74b / 2.73b) |
| TATA: -0.04 (NI -4.17m - CFO 64.4m) / TA 1.83b) |
| Beneish M-Score: -1.13k (Cap -4..+1) = AAA |
What is the price of CPS shares?
As of March 26, 2026, the stock is trading at USD 30.00 with a total of 141,100 shares traded.
Over the past week, the price has changed by +3.34%, over one month by -22.66%, over three months by -9.34% and over the past year by +70.16%.
Over the past week, the price has changed by +3.34%, over one month by -22.66%, over three months by -9.34% and over the past year by +70.16%.
Is CPS a buy, sell or hold?
Cooper Stnd has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy CPS.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CPS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.9 | 79.6% |
| Analysts Target Price | 53.9 | 79.6% |
CPS Fundamental Data Overview March 24, 2026
P/E Forward = 62.8931
P/S = 0.1817
P/B = 0.5915
P/EG = 2.22
Revenue TTM = 2.74b USD
EBIT TTM = 52.2m USD
EBITDA TTM = 172.9m USD
Long Term Debt = 1.02b USD (from longTermDebt, last quarter)
Short Term Debt = 104.5m USD (from shortTermDebt, last quarter)
Debt = 1.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.06b USD (from netDebt column, last quarter)
Enterprise Value = 1.57b USD (498.1m + Debt 1.26b - CCE 191.7m)
Interest Coverage Ratio = 0.45 (Ebit TTM 52.2m / Interest Expense TTM 115.9m)
EV/FCF = 96.55x (Enterprise Value 1.57b / FCF TTM 16.2m)
FCF Yield = 1.04% (FCF TTM 16.2m / Enterprise Value 1.57b)
FCF Margin = 0.59% (FCF TTM 16.2m / Revenue TTM 2.74b)
Net Margin = -0.15% (Net Income TTM -4.17m / Revenue TTM 2.74b)
Gross Margin = 11.72% ((Revenue TTM 2.74b - Cost of Revenue TTM 2.42b) / Revenue TTM)
Gross Margin QoQ = 9.50% (prev 12.53%)
Tobins Q-Ratio = 0.86 (Enterprise Value 1.57b / Total Assets 1.83b)
Interest Expense / Debt = 2.28% (Interest Expense 28.7m / Debt 1.26b)
Taxrate = 21.0% (US default 21%)
NOPAT = 41.2m (EBIT 52.2m * (1 - 21.00%))
Current Ratio = 1.30 (Total Current Assets 881.1m / Total Current Liabilities 678.4m)
Debt / Equity = -15.12 (negative equity) (Debt 1.26b / totalStockholderEquity, last quarter -83.5m)
Debt / EBITDA = 6.16 (Net Debt 1.06b / EBITDA 172.9m)
Debt / FCF = 65.50 (Net Debt 1.06b / FCF TTM 16.2m)
Total Stockholder Equity = -99.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.23% (Net Income -4.17m / Total Assets 1.83b)
RoE = 4.18% (negative equity) (Net Income TTM -4.17m / Total Stockholder Equity -99.5m)
RoCE = 5.68% (EBIT 52.2m / Capital Employed (Equity -99.5m + L.T.Debt 1.02b))
RoIC = 4.11% (NOPAT 41.2m / Invested Capital 1.00b)
WACC = 5.16% (E(498.1m)/V(1.76b) * Re(13.69%) + D(1.26b)/V(1.76b) * Rd(2.28%) * (1-Tc(0.21)))
Discount Rate = 13.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.69%
[DCF] Terminal Value 82.14% ; FCFF base≈19.5m ; Y1≈13.9m ; Y5≈7.52m
[DCF] Fair Price = N/A (negative equity: EV 234.7m - Net Debt 1.06b = -829.6m; debt exceeds intrinsic value)
EPS Correlation: 58.91 | EPS CAGR: 37.92% | SUE: -0.96 | # QB: 0
Revenue Correlation: 48.03 | Revenue CAGR: 2.50% | SUE: 1.67 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.86 | Chg7d=+0.042 | Chg30d=+0.040 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=2.65 | Chg7d=+0.103 | Chg30d=+0.285 | Revisions Net=+0 | Growth EPS=+253.4% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=4.46 | Chg7d=+0.127 | Chg30d=+0.648 | Revisions Net=+0 | Growth EPS=+68.1% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
P/S = 0.1817
P/B = 0.5915
P/EG = 2.22
Revenue TTM = 2.74b USD
EBIT TTM = 52.2m USD
EBITDA TTM = 172.9m USD
Long Term Debt = 1.02b USD (from longTermDebt, last quarter)
Short Term Debt = 104.5m USD (from shortTermDebt, last quarter)
Debt = 1.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.06b USD (from netDebt column, last quarter)
Enterprise Value = 1.57b USD (498.1m + Debt 1.26b - CCE 191.7m)
Interest Coverage Ratio = 0.45 (Ebit TTM 52.2m / Interest Expense TTM 115.9m)
EV/FCF = 96.55x (Enterprise Value 1.57b / FCF TTM 16.2m)
FCF Yield = 1.04% (FCF TTM 16.2m / Enterprise Value 1.57b)
FCF Margin = 0.59% (FCF TTM 16.2m / Revenue TTM 2.74b)
Net Margin = -0.15% (Net Income TTM -4.17m / Revenue TTM 2.74b)
Gross Margin = 11.72% ((Revenue TTM 2.74b - Cost of Revenue TTM 2.42b) / Revenue TTM)
Gross Margin QoQ = 9.50% (prev 12.53%)
Tobins Q-Ratio = 0.86 (Enterprise Value 1.57b / Total Assets 1.83b)
Interest Expense / Debt = 2.28% (Interest Expense 28.7m / Debt 1.26b)
Taxrate = 21.0% (US default 21%)
NOPAT = 41.2m (EBIT 52.2m * (1 - 21.00%))
Current Ratio = 1.30 (Total Current Assets 881.1m / Total Current Liabilities 678.4m)
Debt / Equity = -15.12 (negative equity) (Debt 1.26b / totalStockholderEquity, last quarter -83.5m)
Debt / EBITDA = 6.16 (Net Debt 1.06b / EBITDA 172.9m)
Debt / FCF = 65.50 (Net Debt 1.06b / FCF TTM 16.2m)
Total Stockholder Equity = -99.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.23% (Net Income -4.17m / Total Assets 1.83b)
RoE = 4.18% (negative equity) (Net Income TTM -4.17m / Total Stockholder Equity -99.5m)
RoCE = 5.68% (EBIT 52.2m / Capital Employed (Equity -99.5m + L.T.Debt 1.02b))
RoIC = 4.11% (NOPAT 41.2m / Invested Capital 1.00b)
WACC = 5.16% (E(498.1m)/V(1.76b) * Re(13.69%) + D(1.26b)/V(1.76b) * Rd(2.28%) * (1-Tc(0.21)))
Discount Rate = 13.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.69%
[DCF] Terminal Value 82.14% ; FCFF base≈19.5m ; Y1≈13.9m ; Y5≈7.52m
[DCF] Fair Price = N/A (negative equity: EV 234.7m - Net Debt 1.06b = -829.6m; debt exceeds intrinsic value)
EPS Correlation: 58.91 | EPS CAGR: 37.92% | SUE: -0.96 | # QB: 0
Revenue Correlation: 48.03 | Revenue CAGR: 2.50% | SUE: 1.67 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.86 | Chg7d=+0.042 | Chg30d=+0.040 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=2.65 | Chg7d=+0.103 | Chg30d=+0.285 | Revisions Net=+0 | Growth EPS=+253.4% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=4.46 | Chg7d=+0.127 | Chg30d=+0.648 | Revisions Net=+0 | Growth EPS=+68.1% | Growth Revenue=+6.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)